Foresee Pharmaceuticals Co Ltd Cash Flow Quality Index

Latest as of June 2022: 6.56x

Foresee Pharmaceuticals Co Ltd cash flow quality index. Foresee Pharmaceuticals Co Ltd (6576) has a Cash Flow Quality Index of 6.56x as of June 2022. Operating cash flow of NT$143.03 Million exceeds net income of NT$21.80 Million, indicating high earnings quality where cash backs reported profits. See Foresee Pharmaceuticals Co Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

6.56x
Operating CF / Net Income

Operating Cash Flow

NT$143.03 Million
TWD

Net Income

NT$21.80 Million
TWD

Data as of

Jun 2022
Most recent filing

Foresee Pharmaceuticals Co Ltd Cash Flow Quality Index by Year (None–None)

Foresee Pharmaceuticals Co Ltd cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Foresee Pharmaceuticals Co Ltd. For the full cash flow conversion analysis, see Foresee Pharmaceuticals Co Ltd cash conversion from operations.

Year Quality Index Operating CF (TWD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.